Global Human Identification Market Size By Type (Capillary Electrophoresis, Polymerase Chain Reaction), By Application (Forensic Laboratories, Hospitals), By Region, And Segment Forecasts, 2023 to 203...

The Global Human Identification Market was valued at USD 2.1 billion in 2023 and is projected to reach USD 4.2 billion by 2031, growing at a CAGR of 9.1% during the forecast period from 2023 to 2031. Human identification is critical in forensic investigations, disaster victim identification, paternity testing, and anthropological studies. The increasing demand for advanced DNA analysis technologies, rising crime rates, and the growth of forensic laboratories worldwide are driving the expansion of the market.

The integration of next-generation sequencing (NGS), automation in sample preparation, and the expansion of biometric systems are reshaping the landscape of human identification, making processes faster, more accurate, and scalable for mass screening.

Drivers:

1. Rising Demand for DNA Analysis in Forensics:

Growing incidences of crimes and the need for rapid resolution of criminal cases are driving investments in DNA profiling technologies. Forensic applications are the largest and most mature segment of the market.

2. Technological Advancements in Genomics and Molecular Biology:

Innovations such as STR (short tandem repeat) analysis, mtDNA sequencing, and rapid DNA technologies are enhancing the accuracy and efficiency of human identification processes.

3. Government Support and Funding for Forensic Science:

Increased government funding for improving national forensic capabilities and crime laboratories globally is accelerating the deployment of advanced identification systems.

Restraints:

1. High Costs of Advanced DNA Analysis Tools:

Despite the technological benefits, the high cost of NGS systems, consumables, and skilled labor can limit adoption, especially in developing economies.

2. Ethical and Privacy Concerns:

Human identification involves sensitive personal data, raising ethical questions around consent, storage, and use of biometric and genetic information.

Opportunity:

1. Growth of Biobanks and Population Genetics Studies:

Expanding biobanks and genomic databases are facilitating broader human identification capabilities beyond law enforcement, into healthcare, genealogy, and research.

2. Emerging Markets and Infrastructure Expansion:

Asia-Pacific, Latin America, and parts of Africa are witnessing rapid infrastructure development in forensic science, creating new opportunities for market penetration.

Market by System Type Insights:

Based on system type, the DNA Amplification and Extraction Systems segment dominated the market in 2023, owing to their pivotal role in sample processing and compatibility with multiple downstream analysis methods. These systems are widely adopted in forensic and research laboratories for their reliability and throughput efficiency. The Next-Generation Sequencing (NGS) Systems segment is expected to register the highest growth, driven by its applications in complex and degraded sample analysis.

Market by End-use Insights:

The Forensic Laboratories segment held the largest market share in 2023, accounting for over 45% of global revenue. These labs rely heavily on human identification for criminal investigations, missing persons identification, and legal proceedings. The Research Institutions and Academic Centers segment is anticipated to grow rapidly, fueled by advancements in genomic research and anthropology.

Market by Regional Insights:

North America dominated the global human identification market in 2023, backed by robust forensic infrastructure, favorable government policies, and technological leadership in genomics. Meanwhile, Asia-Pacific is projected to be the fastest-growing region during the forecast period, driven by rising investments in forensic sciences, growing crime rates, and improvements in law enforcement technologies in countries like India, China, and Japan.

Competitive Scenario:

Key players in the global human identification market include Thermo Fisher Scientific Inc., Promega Corporation, QIAGEN N.V., Verogen Inc., Agilent Technologies, GE Healthcare, Bio-Rad Laboratories Inc., Illumina Inc., LGC Ltd., and Hamilton Company. These companies are investing in R&D, entering strategic partnerships, and launching innovative products to expand their market share.

Key Developments:

2023: Thermo Fisher Scientific launched an enhanced STR kit with improved sensitivity for degraded DNA samples.

2024: Illumina Inc. collaborated with national forensics labs in Europe to implement NGS platforms for complex casework.

2025: Promega Corporation introduced a fully automated human identification workflow, reducing turnaround time in crime labs.

Scope of Work – Global Human Identification Market

Report Metric Details

Market Size (2023) USD 2.1 billion

Projected Market Size (2031) USD 4.2 billion

CAGR (2023–2031) 9.1%

Market Segments System Type (STR Analysis, NGS, Capillary Electrophoresis), End-use (Forensic Labs, Research Institutions, Government Agencies)

Growth Drivers Rising crime rates, technological advancements in DNA profiling, forensic infrastructure development

Opportunities Adoption of NGS, expansion in emerging markets, biobank integration

FAQs:

1. What is the current market size of the Global Human Identification Market?

The market was valued at USD 2.1 billion in 2023.

2. What is the major growth driver of the Global Human Identification Market?

The primary driver is the rising demand for DNA profiling in forensics and law enforcement.

3. Which is the largest region during the forecast period in the Global Human Identification Market?

North America currently holds the largest market share, with Asia-Pacific expected to grow fastest.

4. Which segment accounted for the largest market share in the Global Human Identification Market?

The Forensic Laboratories segment held the largest share in 2023.

5. Who are the key market players in the Global Human Identification Market?

Thermo Fisher Scientific, Promega Corporation, QIAGEN N.V., Verogen Inc., and Illumina Inc. are among the leading players.